In Figure 1A, the expression level of CD93 was significantly upregulated in six cancer types (i.e., CHOL, GBM, KIRC, LIHC, STAD, and THCA; all p < 0.01) and downregulated in 10 cancer types (i.e., BLCA, BRCA, CESC, COAD, HNSC, KICH, KIRP, LUAD, LUSC, and UCEC; all p < 0.01) when compared with corresponding normal tissues. Here, CD93 is linked to cancer.